Jane Street Group, LLC Regenxbio Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$19.35 - $35.04 $141,255 - $255,792	-7,300 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$24.62 - $34.31 $396,382 - $552,391	-16,100 Reduced 68.8%	7,300 $242,000
Q4 2021 Feb 15, 2022	SELL	$30.19 - $40.28 $205,292 - $273,904	-6,800 Reduced 22.52%	23,400 $765,000
Q3 2021 Nov 16, 2021	BUY	$29.09 - $45.68 $299,627 - $470,504	10,300 Added 51.76%	30,200 $1.27 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $434,964 - $542,432	13,400 Added 206.15%	19,900 $773,000
Q4 2020 Feb 17, 2021	SELL	$26.52 - $49.35 $676,260 - $1.26 Million	-25,500 Reduced 79.69%	6,500 $295,000
Q3 2020 Nov 17, 2020	BUY	$27.01 - $40.26 $688,755 - $1.03 Million	25,500 Added 392.31%	32,000 $881,000
Q2 2020 Aug 17, 2020	BUY	$27.75 - $43.44 $180,375 - $282,360	6,500 New	6,500 $239,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $313M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.